The University of Chicago Header Logo

Connection

Mark Talamonti to Cancer Vaccines

Back to Details
This is a "connection" page, showing publications Mark Talamonti has written about Cancer Vaccines.
Mark Talamonti
Connection Strength
0.095
Cancer Vaccines
  1. Addition of algenpantucel-L immunotherapy to standard adjuvant therapy for pancreatic cancer: a phase 2 study. J Gastrointest Surg. 2013 Jan; 17(1):94-100; discussion p. 100-1.
    View in: PubMed
    Score: 0.095
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.